Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

P. L. Zinzani, M. Bendandi, B. Gamberi, M. Magagnoli, F. Gherlinzoni, S. Tura

Research output: Contribution to journalArticlepeer-review

Abstract

Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.

Original languageEnglish
Pages (from-to)437-438
Number of pages2
JournalHaematologica
Volume85
Issue number4
Publication statusPublished - 2000

Keywords

  • Aggressive lymphoma
  • Molecular remission
  • Rituximab

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma'. Together they form a unique fingerprint.

Cite this